[go: up one dir, main page]

NO20051892L - New connection - Google Patents

New connection

Info

Publication number
NO20051892L
NO20051892L NO20051892A NO20051892A NO20051892L NO 20051892 L NO20051892 L NO 20051892L NO 20051892 A NO20051892 A NO 20051892A NO 20051892 A NO20051892 A NO 20051892A NO 20051892 L NO20051892 L NO 20051892L
Authority
NO
Norway
Prior art keywords
new connection
solvates
therapy
compound
formula
Prior art date
Application number
NO20051892A
Other languages
Norwegian (no)
Inventor
Roger Victor Bonnert
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20051892L publication Critical patent/NO20051892L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

En forbindelse med formel (I) og farmasøytisk akseptable salter eller solvater derav for anvendelse i terapi.A compound of formula (I) and pharmaceutically acceptable salts or solvates thereof for use in therapy.

NO20051892A 2002-09-20 2005-04-19 New connection NO20051892L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0221828.7A GB0221828D0 (en) 2002-09-20 2002-09-20 Novel compound
PCT/GB2003/003998 WO2004026880A1 (en) 2002-09-20 2003-09-16 Novel compound

Publications (1)

Publication Number Publication Date
NO20051892L true NO20051892L (en) 2005-06-17

Family

ID=9944428

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051892A NO20051892L (en) 2002-09-20 2005-04-19 New connection

Country Status (26)

Country Link
US (2) US7585867B2 (en)
EP (1) EP1543013B1 (en)
JP (1) JP4619787B2 (en)
KR (1) KR20050057427A (en)
CN (1) CN1315848C (en)
AR (1) AR041340A1 (en)
AT (1) ATE419254T1 (en)
AU (1) AU2003267571B2 (en)
BR (1) BR0314844A (en)
CA (1) CA2498762A1 (en)
DE (1) DE60325614D1 (en)
DK (1) DK1543013T3 (en)
ES (1) ES2318152T3 (en)
GB (1) GB0221828D0 (en)
IS (1) IS7793A (en)
MX (1) MXPA05002935A (en)
NO (1) NO20051892L (en)
NZ (1) NZ538826A (en)
PL (1) PL375952A1 (en)
PT (1) PT1543013E (en)
RU (1) RU2342389C2 (en)
SI (1) SI1543013T1 (en)
TW (1) TW200413395A (en)
UA (1) UA81257C2 (en)
WO (1) WO2004026880A1 (en)
ZA (1) ZA200502272B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903544D0 (en) 1999-10-01 1999-10-01 Astra Pharma Prod Novel compounds
GB2359551A (en) * 2000-02-23 2001-08-29 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
SE0003828D0 (en) 2000-10-20 2000-10-20 Astrazeneca Ab Novel compounds
SE0102716D0 (en) * 2001-08-14 2001-08-14 Astrazeneca Ab Novel compounds
GB0221829D0 (en) * 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
GB0221828D0 (en) 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
GB0328243D0 (en) * 2003-12-05 2004-01-07 Astrazeneca Ab Methods
AR053347A1 (en) * 2005-04-06 2007-05-02 Astrazeneca Ab DERIVATIVES OF [1,3] TIAZOLO [4,5-D] PYRIMIDIN-2 (3H) -ONA 5,7-SUBSTITUTED
UA90707C2 (en) 2005-04-06 2010-05-25 Астразенека Аб Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives
AU2006278627B2 (en) * 2005-08-08 2011-08-18 Janssen Pharmaceutica, N.V. Thiazolopyrimidine kinase inhibitors
PE20080145A1 (en) 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv TETRAHYDRO-PYRIMIDOAZEPINE AS MODULATORS OF TRPV1
TW200820973A (en) * 2006-09-29 2008-05-16 Astrazeneca Ab Novel compounds 480
JP5562865B2 (en) 2007-12-17 2014-07-30 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ TRPV1 imidazolo-, oxazolo-, and thiazolopyrimidine modulators
AR071036A1 (en) * 2008-03-26 2010-05-19 Astrazeneca Ab DERIVATIVES 5, 7-DISUSTITUTES OF [1, 3] TIAZOLO [4, 5-D] PIRIMIDIN-2 (3H) -ONA, A PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS AND ITS USE IN THE TREATMENT OF DISEASES MEDIATED BY THE CX3CR1 RECEIVER.
WO2009151910A2 (en) * 2008-05-25 2009-12-17 Wyeth Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer
CN102822163B (en) 2009-12-23 2016-01-20 艾恩伍德医药品股份有限公司 CRTH2 modulator
US20130216552A1 (en) 2010-07-12 2013-08-22 Ironwood Pharmaceuticals, Inc. Crth2 modulators
WO2012009134A1 (en) 2010-07-12 2012-01-19 Ironwood Pharmaceuticals, Inc. Crth2 modulators

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2924472A (en) 1957-06-27 1960-02-09 Gen Motors Corp Pipe joint seal
GB1009477A (en) 1962-02-13 1965-11-10 Smith Kline French Lab Novel process for preparing heterocyclic compounds
US3318900A (en) 1964-05-06 1967-05-09 Janssen Pharmaceutica Nv Derivatives of benzimidazolinyl piperidine
BE668603A (en) 1964-08-20
BE791242A (en) * 1971-11-11 1973-05-10 Thomae Gmbh Dr K NEWS THIAZOLO (5,4-D) PYRIMIDINES
DE2331223C2 (en) 1972-06-19 1984-11-22 Kohjin Co., Ltd., Tokio / Tokyo S-substituted-2-thioadenosines, their 5'-monophosphates, processes for their preparation and pharmaceuticals containing them
US4120521A (en) 1975-08-28 1978-10-17 Rieber & Son Plastic-Industri A/S Combined mould element and sealing ring
EG12406A (en) 1976-08-12 1979-03-31 Janssen Pharmaceutica Nv Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
GB1600293A (en) 1977-02-04 1981-10-14 British Oceanics Ltd Sealing arrangements
US4188040A (en) 1977-04-06 1980-02-12 Firma WOCO Franz-Josef Wolf & Co. Sealing ring
DE2726959A1 (en) 1977-06-15 1979-01-18 Arlt Christian SEALING INSERT FOR SEALING TWO TUBES
FR2421899A1 (en) 1978-01-16 1979-11-02 Roussel Uclaf NEW TETRAHYDROPYRIDINYL-INDOLE DERIVATIVES AND THEIR SALTS, THE PREPARATION PROCESS AND THE MEDICINAL APPLICATION OF THESE NEW PRODUCTS
US4410528A (en) 1980-05-16 1983-10-18 Kyowa Hakko Kogyo Co., Ltd. Hypotensive piperidine derivatives
DE3219522A1 (en) 1981-10-28 1983-12-01 Denso-Chemie Wedekind Kg, 5090 Leverkusen CONNECTOR SEAL FOR PIPES
FR2547888B1 (en) 1983-06-22 1985-12-13 Sabla Sa IMPLANT SEALING RING FOR INTERLOCKING PIPES
CA1338012C (en) 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
SE8800348L (en) 1988-02-03 1989-08-04 Forsheda Ab SEALING RING AND TOOLS FOR PRODUCING THEREOF
FR2659656B1 (en) 1990-03-15 1994-09-09 Sanofi Sa PYRIMIDINEDIONE-2,4 DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM.
DE4119767A1 (en) 1991-06-15 1992-12-17 Dresden Arzneimittel Prepn. of (pyrimid-2-yl-thio- or seleno-) acetic acid derivs. - by reacting the corresp. chloro:alkanoyl-amino cpd. with a rhodanide and water or an alcohol
US5169161A (en) 1991-09-19 1992-12-08 Hail Mary Rubber Co., Inc. Symmetrical gasket for pipe joints
DE4134089C2 (en) 1991-10-15 1994-10-13 Dueker Eisenwerk Thrust-proof sleeve connection
JPH05188994A (en) 1992-01-07 1993-07-30 Sony Corp Noise suppressor
DE4229609C2 (en) 1992-09-04 2003-05-08 Forsheda Stefa Gmbh Sealing between two interlocking parts
US5521197A (en) 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
ATE243697T1 (en) 1995-12-08 2003-07-15 Pfizer SUBSTITUTED HETEROCYCLIC DERIVATIVES AS CRF ANTAGONISTS
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
SE515033C2 (en) 1995-12-27 2001-06-05 Forsheda Ab sealing device
BR9707495A (en) 1996-02-13 1999-07-27 Zeneca Ltd Quinazoline derivative process for the preparation of the same pharmaceutical composition and process for the production of an antiangiogenic effect and / or reduction of vascular permeability in a warm-blooded animal
AU719327B2 (en) 1996-03-05 2000-05-04 Astrazeneca Ab 4-anilinoquinazoline derivatives
EP0898568B1 (en) 1996-04-19 2006-10-04 Neurosearch A/S 1-(4-piperidyl)-benzimidazoles having neurotrophic activity
IL127566A0 (en) 1996-08-28 1999-10-28 Pfizer Substituted 6,5-hetero- bicyclic derivatives
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
WO1998025617A1 (en) 1996-12-13 1998-06-18 Merck & Co., Inc. Substituted aryl piperazines as modulators of chemokine receptor activity
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
EP1003514A4 (en) 1997-07-25 2000-10-11 Merck & Co Inc CYCLIC AMINES MODULATING THE ACTIVITY OF CHIMIOKIN RECEPTORS
AR013669A1 (en) 1997-10-07 2001-01-10 Smithkline Beecham Corp COMPOUNDS AND METHODS
ES2205573T3 (en) 1997-11-28 2004-05-01 Sumitomo Pharmaceuticals Company, Limited NEW HETEROCICLIC COMPOUNDS.
US6423725B1 (en) 1998-01-19 2002-07-23 Pfizer Inc 4-(2-keto-1-benzimidazolinyl)piperidine compounds as ORL1-receptor agonists
KR20010042001A (en) 1998-03-19 2001-05-25 무라타 도시카즈 Arylpiperidine derivatives and use thereof
CA2326884A1 (en) 1998-04-03 1999-10-14 Dupont Pharmaceuticals Company Thiazolo¬4,5-d|pyrimidines and pyridines as corticotropin releasing factor (crf) antagonists
MA26659A1 (en) 1998-08-06 2004-12-20 Pfizer NOVEL BENZIMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION.
SE9802729D0 (en) 1998-08-13 1998-08-13 Astra Pharma Prod Novel Compounds
US5988695A (en) 1998-08-26 1999-11-23 S&B Technical Products, Inc. Pipe gasket with embedded ring
PE20001420A1 (en) 1998-12-23 2000-12-18 Pfizer CCR5 MODULATORS
WO2000039129A1 (en) 1998-12-28 2000-07-06 K.U. Leuven Research & Development Immunosuppressive effects of pteridine derivatives
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
WO2000045800A2 (en) 1999-02-02 2000-08-10 K.U. Leuven Research & Development Immunosurpressive effects of pteridine derivatives
US6248755B1 (en) 1999-04-06 2001-06-19 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
US6142484A (en) 1999-04-15 2000-11-07 Vassallo Research & Development Corporation Composite multi-pressure gasket
WO2000076514A1 (en) 1999-06-11 2000-12-21 Merck & Co., Inc. Cyclopentyl modulators of chemokine receptor activity
US6340681B1 (en) 1999-07-16 2002-01-22 Pfizer Inc 2-benzimidazolylamine compounds as ORL-1-receptor agonists
WO2001019825A1 (en) 1999-09-15 2001-03-22 Warner-Lambert Company Pteridinones as kinase inhibitors
AR025884A1 (en) 1999-10-01 2002-12-18 Takeda Pharmaceutical CYCLINE AMINE COMPOUNDS, ITS PRODUCTION AND USE
SE9903544D0 (en) 1999-10-01 1999-10-01 Astra Pharma Prod Novel compounds
ATE306488T1 (en) 2000-01-05 2005-10-15 Pfizer BENZIMIDAZOLE COMPOUNDS FOR USE AS ORL1 RECEPTOR ANTAGONISTS
GB2359079A (en) 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
GB2359081A (en) 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active thiazolopyrimidines
GB2359078A (en) 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
WO2001058906A1 (en) 2000-02-11 2001-08-16 Astrazeneca Ab Pyrimidine compounds and their use as modulators of chemokine receptor activity
GB2359551A (en) 2000-02-23 2001-08-29 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
GB0005642D0 (en) 2000-03-10 2000-05-03 Astrazeneca Uk Ltd Chemical compounds
AU2001242744B2 (en) 2000-03-24 2005-07-21 Meiji Seika Kaisha Ltd Diphenylalkylamine derivatives useful as opioid delta receptor ligands
IL152682A0 (en) 2000-05-31 2003-06-24 Astrazeneca Ab Indole derivatives with vascular damaging activity
KR20030022264A (en) 2000-07-07 2003-03-15 앤지오젠 파마슈티칼스 리미티드 Colchinol derivatives as angiogenesis inhibitors
WO2002004434A1 (en) 2000-07-07 2002-01-17 Angiogene Pharmaceuticals Limited Colchinol derivatives as vascular damaging agents
SE0003828D0 (en) 2000-10-20 2000-10-20 Astrazeneca Ab Novel compounds
SE0004110L (en) 2000-11-10 2002-05-11 Forsheda Ab LUTE
SE0101322D0 (en) 2001-04-12 2001-04-12 Astrazeneca Ab Novel compounds
SE0102716D0 (en) 2001-08-14 2001-08-14 Astrazeneca Ab Novel compounds
GB0221828D0 (en) 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
GB0221829D0 (en) 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
US20070142386A1 (en) 2003-10-07 2007-06-21 Astrazeneca New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1
GB0328243D0 (en) 2003-12-05 2004-01-07 Astrazeneca Ab Methods
WO2005082865A1 (en) 2004-02-27 2005-09-09 Astellas Pharma Inc. Fused bicyclic pyrimidine derivative
EP1844054A2 (en) 2004-12-17 2007-10-17 AstraZeneca AB Thiazolopyrimidine compounds for the modulation of chemokine receptor activity

Also Published As

Publication number Publication date
GB0221828D0 (en) 2002-10-30
SI1543013T1 (en) 2009-04-30
AU2003267571A1 (en) 2004-04-08
CA2498762A1 (en) 2004-04-01
KR20050057427A (en) 2005-06-16
UA81257C2 (en) 2007-12-25
IS7793A (en) 2005-04-11
ATE419254T1 (en) 2009-01-15
EP1543013B1 (en) 2008-12-31
CN1681826A (en) 2005-10-12
JP4619787B2 (en) 2011-01-26
PL375952A1 (en) 2005-12-12
ES2318152T3 (en) 2009-05-01
US7585867B2 (en) 2009-09-08
DE60325614D1 (en) 2009-02-12
AU2003267571B2 (en) 2007-08-16
CN1315848C (en) 2007-05-16
RU2005106356A (en) 2005-11-20
RU2342389C2 (en) 2008-12-27
JP2006503835A (en) 2006-02-02
WO2004026880A1 (en) 2004-04-01
NZ538826A (en) 2006-12-22
HK1077060A1 (en) 2006-02-03
AR041340A1 (en) 2005-05-11
DK1543013T3 (en) 2009-03-09
US20080306262A1 (en) 2008-12-11
ZA200502272B (en) 2005-09-19
EP1543013A1 (en) 2005-06-22
MXPA05002935A (en) 2005-05-27
BR0314844A (en) 2005-08-09
TW200413395A (en) 2004-08-01
US20060100221A1 (en) 2006-05-11
PT1543013E (en) 2009-02-27

Similar Documents

Publication Publication Date Title
NO20051892L (en) New connection
NO20051893L (en) New connection
NO20025821L (en) 2-aminocarbonyl-9H-purine
NO20021328L (en) Pyrazolopyrimidia as therapeutic agents
IL165262A (en) Kinase inhibitors and pharmaceutical compositions containing them
NO20044866L (en) Pyrazolo-pyrimidine-aniline compounds useful as kinase inhibitors
DE60112974D1 (en) Carbolinderivate
NO20054848L (en) Substituted p-diaminobenzene derivatives
MXPA04001889A (en) Alkyne-aryl phosphodiesterase-4 inhibitors.
GB0111523D0 (en) Chemical compounds
ATE394383T1 (en) BIPHENYL CARBONIC ACID AMIDE DERIVATIVES AS P38 KINASE INHIBITORS
MXPA03008215A (en) INHIBITORS OF INTEGRIN agr;v.
NO20065904L (en) Therapeutic compounds
DE60121461D1 (en) CONDENSED PYRIDOINDOL DERIVATIVES
ATE303384T1 (en) 1-BIARYL-1,8-NAPHTHYRIDINE-4-ONE AS PHOSPHODIESETERASE INHIBITORS
AU2002249890A1 (en) Carboline derivatives
ATE402175T1 (en) 4-OXO-1-(3-SUBSTITUTEDPHENYL)-1,4-DIHYDRO-1, - NAPHTHYRIDINE-3-CARBONIC ACID AMIDE ALSPHOSHODIESTERASE-4 INHIBITORS
CY1106544T1 (en) METHOD OF SYNTHESIS OF HYPERINDOPRIL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
GB0314967D0 (en) Piperazine derivatives
WO2002070469A3 (en) Selective pde3b inhibitors and use of the same in therapy
NO20052182L (en) New connections
NO20060146L (en) Benzimidazole derivatives, compositions containing them, their preparation and their use
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
EA200501557A1 (en) NEW METHOD OF SYNTHESIS (2S) -INDOLIN-2-CARBONIC ACID AND USE IN PERINDOPRIL SYNTHESIS
DE60121048D1 (en) PYRAZINOi1&#39;2 &#39;: 1,6öPYRIDOi3,4-BöINDOLDERIVATE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application